Mounjaro
NDC 0002-4210 · Eli Lilly and Company
Generic nametirzepatide
Dosage formINJECTION, SOLUTION
RouteSUBCUTANEOUS
Active ingredient(s)TIRZEPATIDE
Strength12.5 mg/mL
Pharmacologic classG-Protein-linked Receptor Interactions [MoA], GLP-1 Receptor Agonist [EPC], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA], Glucose-dependent Insulinotropic Polypeptide Receptor Agonist [EPC]
Marketing categoryNDA
Packages
0002-4210-11 — 1 VIAL, MULTI-DOSE in 1 CARTON (0002-4210-11) / 2.4 mL in 1 VIAL, MULTI-DOSE (0002-4210-01)
Related Codes
Same active ingredient
FDA lists these products with the same active ingredient.
0002-3455 — tirzepatide, 0002-3466 — tirzepatide, 0002-3511 — tirzepatide, 0002-3522 — tirzepatide, 0002-3533 — tirzepatide, 0002-3544 — tirzepatide, 0002-3555 — tirzepatide, 0002-3566 — tirzepatide, 0002-4052 — tirzepatide, 0002-4103 — tirzepatide, 0002-4304 — tirzepatide, 0002-4523 — tirzepatide, 0002-4612 — tirzepatide, 0002-6052 — tirzepatide, 0002-6103 — tirzepatide, 0002-6210 — tirzepatide, 0002-6304 — tirzepatide, 0002-6523 — tirzepatide, 0002-6612 — tirzepatide, 50090-8021 — tirzepatide, +33 more